X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

INFECTION GENETICS AND EVOLUTION

期刊標題檢索 INFECT GENET EV 最新評論: Direct employment after major repairs, with fast review speed and cons... (2023-07-12)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[INFECTION GENETICS AND EVOLUTION]您好,您是該頁面的第 50044 位訪客。

期刊簡介
期刊名稱INFECTION GENETICS AND EVOLUTION INFECTION GENETICS AND EVOLUTION
LetPub Score
6.6
51 ratings
Rate

Reputation
7.6

Influence
5.3

Speed
8.8

期刊簡稱INFECT GENET EVOL
ISSN1567-1348
E-ISSN1567-7257
h-index74
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.400.7180.744
Subject fieldQuartilesRankPercentile
Category: Agricultural and Biological Sciences
Subcategory: Ecology, Evolution, Behavior and Systematics
Q155 / 721
Category: Agricultural and Biological Sciences
Subcategory: Infectious Diseases
Q163 / 344
Category: Agricultural and Biological Sciences
Subcategory: Genetics
Q167 / 347
Category: Agricultural and Biological Sciences
Subcategory: Microbiology (medical)
Q133 / 140
Category: Agricultural and Biological Sciences
Subcategory: Microbiology
Q143 / 182
Category: Agricultural and Biological Sciences
Subcategory: Molecular Biology
Q2111 / 410

自引率 (2023-2024)3.80%自引率趨勢
掲載範囲
(aka Journal of Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases -- MEEGID)

Infectious diseases constitute one of the main challenges to medical science in the coming century. The impressive development of molecular megatechnologies and of bioinformatics have greatly increased our knowledge of the evolution, transmission and pathogenicity of infectious diseases. Research has shown that host susceptibility to many infectious diseases has a genetic basis. Furthermore, much is now known on the molecular epidemiology, evolution and virulence of pathogenic agents, as well as their resistance to drugs, vaccines, and antibiotics. Equally, research on the genetics of disease vectors has greatly improved our understanding of their systematics, has increased our capacity to identify target populations for control or intervention, and has provided detailed information on the mechanisms of insecticide resistance.

However, the genetics and evolutionary biology of hosts, pathogens and vectors have tended to develop as three separate fields of research. This artificial compartmentalisation is of concern due to our growing appreciation of the strong co-evolutionary interactions among hosts, pathogens and vectors.

Infection, Genetics and Evolution and its companion congress [MEEGID](http://www.meegidconference.com/) (for Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases) are the main forum acting for the cross-fertilization between evolutionary science and biomedical research on infectious diseases.

Infection, Genetics and Evolution is the only journal that welcomes articles dealing with the genetics and evolutionary biology of hosts, pathogens and vectors, and coevolution processes among them in relation to infection and disease manifestation. All infectious models enter the scope of the journal, including pathogens of humans, animals and plants, either parasites, fungi, bacteria, viruses or prions. The journal welcomes articles dealing with genetics, population genetics, genomics, postgenomics, gene expression, evolutionary biology, population dynamics, mathematical modeling and bioinformatics. We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .
官方網站https://www.journals.elsevier.com/infection-genetics-and-evolution
在線稿件提交http://ees.elsevier.com/meegid/
開放訪問No
出版商Elsevier
主題領域医学
出版國/地區NETHERLANDS
發行頻率四半期刊行
創刊年0
每年文章數136每年文章數趨勢
黃金OA百分比58.39%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
INFECTIOUS DISEASESSCIEQ369/132
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1567-1348%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
來自Elsevier的數據: Average 10.1 Week(s)
競爭力 *來自作者的數據: About 95%
在線文章發布時間來自Elsevier的數據: Average 3.9 Week(s)
參考鏈接
相關期刊 【INFECTION GENETICS AND EVOLUTION】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    LANCET INFECTIOUS DISEASESH-index: 201

    CiteScore: 60.90
    JOURNAL OF INFECTIONH-index: 90

    CiteScore: 45.90
    CLINICAL MICROBIOLOGY AND INFECTIONH-index: 131

    CiteScore: 25.30
    CLINICAL INFECTIOUS DISEASESH-index: 303

    CiteScore: 25.00
    EMERGING INFECTIOUS DISEASESH-index: 202

    CiteScore: 17.30
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICAH-index: 84

    CiteScore: 8.30
    INFECTIONH-index: 66

    CiteScore: 12.50
    JOURNAL OF INFECTIOUS DISEASESH-index: 231

    CiteScore: 13.50
    International Journal of Antimicrobial AgentsH-index: 111

    CiteScore: 21.60
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASESH-index: 73

    CiteScore: 18.90
    學科內最受檢索的期刊 頁面查看次數
    BMC INFECTIOUS DISEASES105480
    JOURNAL OF INFECTIOUS DISEASES100372
    JOURNAL OF INFECTION93421
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES83184
    CLINICAL INFECTIOUS DISEASES79882
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY68685
    International Journal of Antimicrobial Agents67805
    Transboundary and Emerging Diseases67467
    EMERGING INFECTIOUS DISEASES66378
    INFECTION AND IMMUNITY65757
  •  

    INFECTION GENETICS AND EVOLUTION INFECTION GENETICS AND EVOLUTION
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [INFECTION GENETICS AND EVOLUTION] 的評論撰寫評論
作者: 羊岸上的旗


領域: 农林科学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2023-07-12 09:25:51 評論於
Direct employment after major repairs, with fast review speed and constructive suggestions.
(0) 讚! | 羊岸上的旗

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:33:56 評論於
A research article is the main type of research papers published in journals, usually with longer length and larger amount of research data
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:56:58 評論於
In general, the size and length of the article are used to judge the research results
(0) 讚! | 维尔娜菲茨杰拉德

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 17:47:13 評論於
What does the term "research article" mean?
(0) 讚! | 魂魄彦露

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 12:20:54 評論於
How to determine the type of SCI article?
(0) 讚! | 破戒阳平

作者: 气甲松雪


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-24 15:49:47 評論於
How much is the layout fee?
(0) 讚! | 气甲松雪

作者: 明智小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-07-15 22:31:42 評論於
Review speed: 3.0 | Submission hit rate: 75.0 Experience sharing: Veterinary related research paper, submitted on April 6, 2021, revised on June 21, minor revision, revised on July 1, accepted on July 16
(0) 讚! | 明智小公主

作者: 明煦少女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-11-22 08:04:46 評論於
Please translate the following passage into English and Japanese
(0) 讚! | 明煦少女

作者: 安德烈亚伍利


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-02-06 15:30:58 評論於
Do you have to choose the reviewers yourself when submitting an article?
(0) 讚! | 安德烈亚伍利

作者: 安德烈亚伍利


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-12 12:53:58 評論於
Can diabetes foot ulcer be published?
(0) 讚! | 安德烈亚伍利

作者: 安德烈亚伍利


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-12 10:53:30 評論於
Diabetic foot ulcer, genes can be targeted

meimie 2016-06-30 16:10:00 posted: Nearly 4 months of review, too slow, two reviewers, one suggested publication, one praised the article as well written, then said the conclusions were not novel enough and rejected it. Heartbroken, waited so long in vain
(0) 讚! | 安德烈亚伍利

作者: 日月小菊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-08-03 08:38:45 評論於
Review speed: 3.0 | Submission hit rate: 50.0
Experience sharing: I was hit in the past, and got 3 points back then. 2015 2.591 2016 2.885 2017 2.545 2018 2.611
(0) 讚! | 日月小菊

作者: 北国斯伯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-06-11 23:26:51 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0 Experience sharing: One month for the first review, with two reviewers. Major revisions were required, and one month was given for revisions. The second review took half a month, with both reviewers from the first review agreeing to accept the paper. However, a third reviewer was requested, leading to another month for major revisions. The paper was revised within half a month and accepted by the editor in one day. It was online within 5 days, with no page charges. Overall, the efficiency was relatively high
(0) 讚! | 北国斯伯

作者: 明冠岚翠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-06-05 17:12:51 評論於
Received 15 August 2015, revised 18 February 2016, accepted 18 March 2016, available online 25 March 2016
(0) 讚! | 明冠岚翠

作者: 河南省委


領域: 农林科学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2019-06-05 10:06:08 評論於
Received 15 August 2015; Revised 18 February 2016; Accepted 18 March 2016; Available online 25 March 2016.

(0) 讚! | 河南省委

作者: 努力啊大雨华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-01-30 23:58:50 評論於
Review Speed: 3.0 Experience Sharing: Submitted on 10th October 2017, received first major revision three weeks later. Experiment was added on 12th March and revised. Second major revision two weeks later on 15th December, returned for revision on 18th December. Third revision on 5th January 2018 (continued major revision), revised on 21st January 2018. Accepted on 29th January 2018. Overall, it was faster than I expected. Hope this is helpful to everyone
(0) 讚! | 努力啊大雨华

作者: 天欣baby


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-11-17 14:53:36 評論於
Submission to acceptance took 2 months: received major revisions notice around 3 weeks after submission, spent a month on revisions, and accepted a week after resubmission
(0) 讚! | 天欣baby

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 12:05:06 評論於
Everything can only hope for next year, after all, there is no need to worry if the overall trend is up. Even if it only rises a little bit in a year, it will accumulate over time, which is also good
(0) 讚! | 凌霄高洁

作者: 宗室倩丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-06-30 19:47:27 評論於
Review speed: 6.0 | Submission acceptance rate: 50.0
Experience sharing: It took nearly 4 months for the review process, too slow. Two reviewers, one suggested publication and the other praised the writing of the article at first, but later said the conclusion was not innovative enough and rejected it. It's heartbreaking, waited for so long in vain
(0) 讚! | 宗室倩丽

作者: 巴蜀又曼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-06-14 14:29:34 評論於
Three reviewers, one says accept, one says revise, one says reject. And then it gets rejected
(0) 讚! | 巴蜀又曼

作者: 巴蜀又曼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-06-14 10:03:52 評論於
Three reviewers, one said yes, one said revise, and one said reject. And then it got rejected
(0) 讚! | 巴蜀又曼

作者: 江南香卉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-01-14 15:30:25 評論於
Review Speed: 6.0 | Submission Acceptance Rate: 25.0
Experience Sharing: Got one article accepted. 3 reviewers. Review completed in April. Conclusion: Patience pays off
(0) 讚! | 江南香卉

作者: 中原平凡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-08-12 21:45:33 評論於
Two months after submitting the manuscript, the reviewer feedback came back. There were three reviewers, two recommended minor revisions, and one recommended rejection. The editor decided to reject it
(0) 讚! | 中原平凡

作者: 中原平凡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-07-10 23:34:49 評論於
It has been exactly one month since yesterday, and the time for the "under review" status has changed a bit. I'm nervous, but still hoping for the best
(0) 讚! | 中原平凡

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-12-05 23:11:20 評論於
I have been back for a month and a half and still no news. So slow
(0) 讚! | 凌霄高洁

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [INFECTION GENETICS AND EVOLUTION] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*